Skip to main navigation
Skip to main content
Recursion Pharmaceuticals, Inc. Logo
  • Overview
  • News & Events
    Press Releases Events & Presentations
  • Financials & Filings
    SEC Filings Quarterly Results Annual Reports
  • Governance
    Board of Directors Governance Documents Executive Leadership ESG
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Resources
    Email Alerts Contact Us Social Media Disclosure Materials

Quarterly Results

Show all

2024

Q1

  • Press Release
  • 10-Q

Q2

  • Press Release
  • 10-Q

Q3

  • Press Release
  • 10-Q

2023

Q1

  • Press Release
  • 10-Q

Q2

  • Press Release
  • 10-Q

Q3

  • Press Release
  • 10-Q

Q4

  • Press Release
  • Form 10-K

2022

Q1

  • Press Release
  • 10-Q

Q2

  • Press Release
  • 10-Q

Q3

  • Press Release
  • 10-Q

Q4

  • Press Release
  • 10-K

2021

Q1

  • Press Release
  • 10-Q

Q2

  • Press Release
  • 10-Q

Q3

  • Press Release
  • 10-Q

Q4

  • Press Release
  • 10-K

Contact Investor Relations

Investor@Recursion.com

  • Terms of Use
  • Privacy Policy
  • © Recursion Pharmaceuticals, Inc. 2024